86 related articles for article (PubMed ID: 2832280)
21. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist.
Ng SB; Khoury JD
Adv Anat Pathol; 2009 Jan; 16(1):40-55. PubMed ID: 19098466
[TBL] [Abstract][Full Text] [Related]
22. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-associated lymphomas.
Gandhi MK
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
[TBL] [Abstract][Full Text] [Related]
24. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
Klein G; Purtilo D
Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
[No Abstract] [Full Text] [Related]
25. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
[TBL] [Abstract][Full Text] [Related]
26. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
Tsuchiyama L; Kieran J; Boyle P; Wetzel GD
Hum Antibodies; 1997; 8(1):43-7. PubMed ID: 9265505
[TBL] [Abstract][Full Text] [Related]
27. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
28. Use of Epstein-Barr virus to transform fetal human spleen cells for HLA typing.
Mandel TE; Tait BD
Transplantation; 1984 Oct; 38(4):436-7. PubMed ID: 6093295
[No Abstract] [Full Text] [Related]
29. Epstein-Barr virus and T-cell lymphoma.
Lancet; 1988 Sep; 2(8613):723-4. PubMed ID: 2901575
[No Abstract] [Full Text] [Related]
30. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation.
Leech SH; Kumar P
N Engl J Med; 1982 Sep; 307(14):896-7. PubMed ID: 6287264
[No Abstract] [Full Text] [Related]
31. Epstein-Barr virus. Chance and felicity.
Galloway J
Nature; 1989 Apr; 338(6215):463-4. PubMed ID: 2538759
[No Abstract] [Full Text] [Related]
32. Themed issue: the biology and pathology of the Epstein-Barr virus.
Murray PG; Young LS
Mol Pathol; 2000 Oct; 53(5):219-21. PubMed ID: 11091845
[No Abstract] [Full Text] [Related]
33. The role of Epstein-Barr virus in lymphoid malignancies.
Su IJ; Chen JY
Crit Rev Oncol Hematol; 1997 May; 26(1):25-41. PubMed ID: 9246539
[No Abstract] [Full Text] [Related]
34. The B cell-immortalizing functions of Epstein-Barr virus.
Ring CJ
J Gen Virol; 1994 Jan; 75 ( Pt 1)():1-13. PubMed ID: 8113717
[No Abstract] [Full Text] [Related]
35. Identification of the target cells in human B lymphocytes for transformation by Epstein-Barr virus.
Katsuki T; Hinuma Y; Yamamoto N; Abo T; Kumagai K
Virology; 1977 Dec; 83(2):287-94. PubMed ID: 201086
[No Abstract] [Full Text] [Related]
36. Sample age and Epstein-Barr virus transformation of cryopreserved lymphocytes.
Reidy JA; Wheeler VA
In Vitro Cell Dev Biol; 1992 Jun; 28A(6):383-4. PubMed ID: 1321805
[No Abstract] [Full Text] [Related]
37. Epstein-Barr virus strategy in normal and neoplastic B cells.
Klein G
Cell; 1994 Jun; 77(6):791-3. PubMed ID: 8004668
[No Abstract] [Full Text] [Related]
38. Epstein-Barr virus-positive primary brain lymphoma complicating immunoblastic lymphadenopathy.
Yoshimoto S; Yano S; Yamashita M; Taguchi H; Kamimura Y; Ohtsuki Y; Miyoshi I
Acta Haematol; 1985; 74(2):114-5. PubMed ID: 3004097
[TBL] [Abstract][Full Text] [Related]
39. The relative role of viral transformation and specific cytogenetic changes in the development of murine and human lymphomas.
Klein G
Haematol Blood Transfus; 1981; 26():3-10. PubMed ID: 6274749
[No Abstract] [Full Text] [Related]
40. Human lymphocytes transformed with Epstein-Barr virus produce antibodies against sporozoite stage of Plasmodium falciparum.
Monjour L; Alfred C; Ploton I; Desgranges C; Carnevale P; Mazier D; Brandicourt O; Gentilini M
Lancet; 1984 Mar; 1(8375):515. PubMed ID: 6142241
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
